Delavirdine mesylate, >=98% (HPLC)

Delavirdine mesylate, >=98% (HPLC)

Biochem/physiol Actions

Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV) type 1.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Legal Information

Pfizer is a registered trademark of Pfizer, Inc.

Sold for research purposes under agreement from Pfizer Inc.

Other Notes

This compound was developed by Pfizer for Immunology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour mp InChI key InChI Manufacturer Form Assay Price Quantity
3573587 Delavirdine mesylate, >=98% (HPLC) white to tan 315 °C MEPNHSOMXMALDZ-UHFFFAOYSA-N 1S/C22H28N6O3S.CH4O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20;1-5(2,3)4/h4-8,13-15,24-26H,9-12H2,1- SIGMA-ALDRICH powder ≥98% (HPLC)
£608.68 (exc VAT) per 25MG
-
+
3573588 Delavirdine mesylate, >=98% (HPLC) white to tan 315 °C MEPNHSOMXMALDZ-UHFFFAOYSA-N 1S/C22H28N6O3S.CH4O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20;1-5(2,3)4/h4-8,13-15,24-26H,9-12H2,1- SIGMA-ALDRICH powder ≥98% (HPLC)
£174.11 (exc VAT) per 5MG
-
+